IRadimed Corp
IRMD
View Detailed Chart
97.060USD
+0.460+0.48%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
1.23BMarket Cap
58.23P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.48%
5 Days
+3.23%
1 Month
+7.47%
6 Months
+60.48%
Year to Date
+76.47%
1 Year
+79.04%
View Detailed Chart
TradingKey Stock Score of IRadimed Corp
Currency: USD Updated: 2025-12-24Key Insights
IRadimed Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 29/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 99.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IRadimed Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
99.000
Target Price
+3.69%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
IRadimed Corp Highlights
StrengthsRisks
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 37.41% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 73.24M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 73.24M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 29.64%.
Overvalued
The company’s latest PE is 58.23, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 7.41M shares, decreasing 11.47% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 27.00 shares of this stock.
IRadimed Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
IRadimed Corp Info
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Ticker SymbolIRMD
CompanyIRadimed Corp
CEOSusi (Roger)
Websitehttps://www.iradimed.com/
FAQs
What is the current price of IRadimed Corp (IRMD)?
The current price of IRadimed Corp (IRMD) is 97.060.
What is the symbol of IRadimed Corp?
The ticker symbol of IRadimed Corp is IRMD.
What is the 52-week high of IRadimed Corp?
The 52-week high of IRadimed Corp is 98.240.
What is the 52-week low of IRadimed Corp?
The 52-week low of IRadimed Corp is 47.232.
What is the market capitalization of IRadimed Corp?
The market capitalization of IRadimed Corp is 1.23B.
What is the net income of IRadimed Corp?
The net income of IRadimed Corp is 19.23M.
Is IRadimed Corp (IRMD) currently rated as Buy, Hold, or Sell?
According to analysts, IRadimed Corp (IRMD) has an overall rating of Buy, with a price target of 99.000.
What is the Earnings Per Share (EPS TTM) of IRadimed Corp (IRMD)?
The Earnings Per Share (EPS TTM) of IRadimed Corp (IRMD) is 1.667.
Related Instruments
+0.89%
-0.17%
+0.14%
-0.03%
+0.22%
-0.05%
-0.02%
-0.22%
-0.02%
+1.33%
+0.12%
+0.47%
-0.14%
+0.25%
+0.86%
+0.14%
+0.01%
-0.09%
+0.08%
-0.57%
